We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other best ...

A doctor and a patient discussing a therapy plan that includes pharmaceutical products. GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation ...

The GSK oncology products it has sold on to Novartis were ... portfolio against a backdrop of decline elsewhere across its pharma business somewhat calls into question the decision to trade ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said on ...

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it ...

a second-generation anti-histamine and research product of UCB Pharma (Belgium) was launched under a co-marketing agreement. In the same year Glaxo received recognition from the Ministry of ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...